FDA approves Linzess for irritable bowel syndrome, constipation

- Honoring Delmarva Farmers

FDA approves Linzess for irritable bowel syndrome, constipation

Updated:

HealthMore>>
Diet soda habit as bad for teeth as meth addiction
Diet soda habit as bad for teeth as meth addiction
Heavy consumption of diet soda can damage teeth as badly as methamphetamine or crack cocaine, a new study contends.More
Heavy consumption of diet soda can damage teeth as badly as methamphetamine or crack cocaine, a new study contends.More
U.S. teen birth rate plummets
U.S. teen birth rate plummets
Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.More
Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.More
Too few kids use fast-food calorie info
Too few kids use fast-food calorie info
Kids who eat fast food at least twice a week are 50 percent less likely to use calorie and nutritional information than kids who eat fast food less often.More
Kids who eat fast food at least twice a week are 50 percent less likely to use calorie and nutritional information than kids who eat fast food less often.More
American Cancer Society celebrates 100 years of progress
American Cancer Society celebrates 100 years of progress
The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.More
The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.More

THURSDAY, Aug. 30 (HealthDay News) -- Linzess (linaclotide) has been approved by the U.S. Food and Drug Administration to treat forms of chronic constipation that don't respond to traditional treatment, and irritable bowel syndrome accompanied by constipation, the agency said Thursday in a news release.

The National Institutes of Health estimates that some 63 million people are affected by chronic constipation, and about 15.3 million have irritable bowel syndrome (IBS), the FDA said.

Linzess is taken once daily on an empty stomach, at least 30 minutes before the first meal. The most frequently noted adverse reaction is diarrhea.

The drug's label contains a boxed warning that it shouldn't be taken by people aged 16 or younger, the FDA said.

Linzess is produced by Cambridge, Mass.-based Ironwood Pharmaceuticals.

More information

Medline Plus has more about constipation.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.

FDA approves Linzess for irritable bowel syndrome, constipation - WBOC-TV 16, Delmarvas News Leader, FOX 21 -

FDA approves Linzess for irritable bowel syndrome, constipation

HealthMore>>

Diet soda habit as bad for teeth as meth addiction

Diet soda habit as bad for teeth as meth addiction

U.S. teen birth rate plummets

U.S. teen birth rate plummets

Too few kids use fast-food calorie info

Too few kids use fast-food calorie info

American Cancer Society celebrates 100 years of progress

American Cancer Society celebrates 100 years of progress

Delmarvawide News »

Sports »

Can't find what you're looking for?